MAPT and amyloidosis: A second determinant may be necessary in combination with the presence of amyloid plaques to trigger tau conversion, a hypothesis which is supported by the molecular work of Li et al. [20] in mice, which demonstrates that amyloid is necessary, but not sufficient, for pathological conversion of tau.